We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
Read MoreHide Full Article
Intuitive Surgical, Inc. (ISRG - Free Report) ended the recent trading session at $414.52, demonstrating a +2.41% change from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day. Elsewhere, the Dow lost 0.66%, while the tech-heavy Nasdaq lost 0.22%.
The company's shares have seen an increase of 15.59% over the last month, surpassing the Medical sector's loss of 4.73% and the S&P 500's gain of 1.4%.
Investors will be eagerly watching for the performance of Intuitive Surgical, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on October 20, 2026. The company's earnings per share (EPS) are projected to be $2.61, reflecting a 8.75% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $2.88 billion, up 14.98% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $10.74 per share and revenue of $11.74 billion, which would represent changes of +20.27% and +16.67%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Intuitive Surgical, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.35% lower within the past month. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #3 (Hold).
In terms of valuation, Intuitive Surgical, Inc. is presently being traded at a Forward P/E ratio of 37.71. This valuation marks a premium compared to its industry average Forward P/E of 23.11.
We can additionally observe that ISRG currently boasts a PEG ratio of 2.52. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Instruments industry had an average PEG ratio of 2.27 as trading concluded yesterday.
The Medical - Instruments industry is part of the Medical sector. With its current Zacks Industry Rank of 92, this industry ranks in the top 38% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Gains As Market Dips: What You Should Know
Intuitive Surgical, Inc. (ISRG - Free Report) ended the recent trading session at $414.52, demonstrating a +2.41% change from the preceding day's closing price. This change outpaced the S&P 500's 0.22% loss on the day. Elsewhere, the Dow lost 0.66%, while the tech-heavy Nasdaq lost 0.22%.
The company's shares have seen an increase of 15.59% over the last month, surpassing the Medical sector's loss of 4.73% and the S&P 500's gain of 1.4%.
Investors will be eagerly watching for the performance of Intuitive Surgical, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on October 20, 2026. The company's earnings per share (EPS) are projected to be $2.61, reflecting a 8.75% increase from the same quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $2.88 billion, up 14.98% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates are projecting earnings of $10.74 per share and revenue of $11.74 billion, which would represent changes of +20.27% and +16.67%, respectively, from the prior year.
Investors should also take note of any recent adjustments to analyst estimates for Intuitive Surgical, Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, which varies between #1 (Strong Buy) and #5 (Strong Sell), carries an impressive track record of exceeding expectations, confirmed by external audits, with stocks at #1 delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.35% lower within the past month. Right now, Intuitive Surgical, Inc. possesses a Zacks Rank of #3 (Hold).
In terms of valuation, Intuitive Surgical, Inc. is presently being traded at a Forward P/E ratio of 37.71. This valuation marks a premium compared to its industry average Forward P/E of 23.11.
We can additionally observe that ISRG currently boasts a PEG ratio of 2.52. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Medical - Instruments industry had an average PEG ratio of 2.27 as trading concluded yesterday.
The Medical - Instruments industry is part of the Medical sector. With its current Zacks Industry Rank of 92, this industry ranks in the top 38% of all industries, numbering over 250.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions.